Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

被引:59
作者
Rost, D [1 ]
Rudolph, G [1 ]
Kloeters-Plachky, P [1 ]
Stiehl, A [1 ]
机构
[1] Univ Heidelberg, Med Klin, Dept Med, D-69115 Heidelberg, Germany
关键词
D O I
10.1002/hep.20370
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. In primary sclerosing cholangitis (PSC), there is evidence that high doses (+/-20 mg/kg) of UDCA may be more effective than average doses. Biliary enrichment of UDCA at such high doses may represent the decisive factor for its beneficial effect. Up to now it is not clear how high-dose UDCA correlates with its biliary enrichment and whether bacterial degradation of large amounts of UDCA may lead to an increased bacterial formation of more toxic hydrophobic bile acids. We determined the biliary bile acid composition in 56 patients with PSC including 30 patients with repeat bile samples treated with various doses of UDCA. At a UDCA dose of 10 - 13 mg/kg/d (n = 18) biliary UDCA represented 43.1% + 0.3% (mean + SD) of total bile acids; at a UDCA dose of 14-17 mg/kg (n = 14), its biliary content increased to 46.9% + 0.3%, at 18-21 mg/kg (n = 34) to 55.9% + 0.2%, at 22-25 mg/kg (n = 12) to 58.6% + 2.3%, and at 26-32 mg/kg (n = 8) to 57.7% + 0.4%. During UDCA treatment, the biliary content of all other bile acids was unchanged or decreased. In conclusion, biliary enrichment of UDCA increases with increasing dose and reaches a plateau at 22-25 mg/kg. There was no increase of toxic hydrophobic bile acids. If biliary enrichment of UDCA represents the decisive factor for its clinical effect, it seems likely that UDCA doses of up to 22-25 mg/kg may be more effective than lower doses.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 48 条
[11]   Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis - A dose-response study [J].
Crosignani, A ;
Battezzati, PM ;
Setchell, KDR ;
Invernizzi, P ;
Covini, G ;
Zuin, M ;
Podda, M .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (04) :809-815
[12]  
CROSIGNANI A, 1991, HEPATOLOGY, V14, P1000, DOI 10.1002/hep.1840140609
[13]  
FEDOROWSKI T, 1979, GASTROENTEROLOGY, V77, P1068
[14]  
FEDOROWSKI T, 1977, GASTROENTEROLOGY, V73, P1131
[15]   METABOLISM IN MAN OF 7-KETOLITHOCHOLIC ACID - PRECURSOR OF CHENODEOXYCHOLIC AND URSODEOXYCHOLIC ACIDS [J].
FROMM, H ;
CARLSON, GL ;
HOFMANN, AF ;
FARIVAR, S ;
AMIN, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (03) :G161-G166
[16]   URSODEOXYCHOLATE REDUCES HEPATOTOXICITY OF BILE-SALTS IN PRIMARY HUMAN HEPATOCYTES [J].
GALLE, PR ;
THEILMANN, L ;
RAEDSCH, R ;
OTTO, G ;
STIEHL, A .
HEPATOLOGY, 1990, 12 (03) :486-491
[17]  
Harnois DM, 2001, AM J GASTROENTEROL, V96, P1558
[18]   THE CANADIAN MULTICENTER DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS [J].
HEATHCOTE, EJ ;
CAUCHDUDEK, K ;
WALKER, V ;
BAILEY, RJ ;
BLENDIS, LM ;
GHENT, CN ;
MICHIELETTI, P ;
MINUK, GY ;
PAPPAS, SC ;
SCULLY, LJ ;
STEINBRECHER, UP ;
SUTHERLAND, LR ;
WILLIAMS, CN ;
WITTSULLIVAN, H ;
WOROBETZ, LJ ;
MILNER, RA ;
WANLESS, IR .
HEPATOLOGY, 1994, 19 (05) :1149-1156
[19]   CONJUGATES OF URSODEOXYCHOLATE PROTECT AGAINST CHOLESTASIS AND HEPATOCELLULAR NECROSIS CAUSED BY MORE HYDROPHOBIC BILE-SALTS - INVIVO STUDIES IN THE RAT [J].
HEUMAN, DM ;
MILLS, AS ;
MCCALL, J ;
HYLEMON, PB ;
PANDAK, WM ;
VLAHCEVIC, ZR .
GASTROENTEROLOGY, 1991, 100 (01) :203-211
[20]   URSODEOXYCHOLATE CONJUGATES PROTECT AGAINST DISRUPTION OF CHOLESTEROL-RICH MEMBRANES BY BILE-SALTS [J].
HEUMAN, DM ;
BAJAJ, R .
GASTROENTEROLOGY, 1994, 106 (05) :1333-1341